C07K 14/02
Hepadnaviridae
Official title: Hepadnaviridae, e.g. hepatitis B virus
C07K14/02 (Hepadnaviridae) appears on 40 US grants and 63 published applications in this corpus.
Search patents in C07K- Granted patents
- 40
- Published applications
- 63
- Assignees
- 40
- Inventors
- 117
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2012 | 0 | 1 |
| 2013 | 1 | 4 |
| 2014 | 2 | 3 |
| 2015 | 1 | 4 |
| 2016 | 3 | 5 |
| 2017 | 0 | 2 |
| 2018 | 3 | 5 |
| 2019 | 6 | 8 |
| 2020 | 5 | 7 |
| 2021 | 6 | 8 |
| 2022 | 4 | 4 |
| 2023 | 3 | 6 |
| 2024 | 1 | 2 |
| 2025 | 3 | 2 |
| 2026 | 2 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Drug-controlled systems and uses thereof28 Jul 2026US 12,691,096 B2Trustees of Boston University
- Hepadnavirus capsid protein heterodimers and virus-like particles28 Apr 2026US 12,612,433 B2The Trustees of Indiana University
- Human papillomavirus vaccines and uses of the same2 Sep 2025US 12,404,306 B2Precigen, Inc.
- Hepatitis B virus replication inhibitor and pharmaceutical composition for treating hepatitis B comprising the same15 Apr 2025US 12,275,759 B2Riken
- Hepatitis B vaccines and uses of the same25 Feb 2025US 12,234,261 B2Precigen, Inc.
- Modified long peptides suitable for use in immunisation16 Jul 2026US 2026/0200990 A1Isabella Pharma B.V.
- Human papillomavirus vaccines and uses of the same9 Apr 2026US 2026/0098063 A1
- Malaria vaccine17 Jul 2025US 2025/0230197 A1Oxford University Innovation Limited
- Hepatitis b vaccines and uses of the same10 Jul 2025US 2025/0223320 A1Precigen, Inc.
- Hbv vaccine inducing pres-specific neutralizing antibodies21 Nov 2024US 2024/0382584 A1Viravaxx AG
Most cited
By later US patents
- Compositions and methods for the treatment or prevention of hepatitis B virus infection21US 8,722,054 B2GlobeImmune, Inc. · 2014
- Compositions and methods that enhance an immune response11US 8,445,663 B2Chrontech Pharma AB · 2013
- Yeast-based therapeutic for chronic hepatitis B infection5US 8,877,205 B2GlobeImmune, Inc. · 2014
- Nucleic acid molecule encoding hepatitis B virus core protein and vaccine comprising the same5US 9,403,879 B2The Trustees of the University of Pennsylvania · 2016
- Compositions and methods for the treatment or prevention of hepatitis B virus infection5US 9,428,556 B2GlobeImmune, Inc. · 2016